Finasteride
Product Images NDC 54868-5636

6 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 54868-5636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 5 mg Package Label (5mg Package Label)

Image Of 5 mg Package Label (5mg Package Label)
Finasteride 5 mg tablets packaging label from Physicians Total Care, Inc. The label states 90 tablets per container, includes caution about prescription dispensing, lists NDC 54868-5636-1, and provides storage instructions to keep the product at controlled room temperature, protected from light and moisture. Manufacturing and expiration dates, lot number, and barcode are visible on the label.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of finasteride, showing its multi-ring steroid-like framework with a nitrogen-containing lactam ring and various functional groups attached.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A line graph comparing the mean change from baseline over time between Placebo and Finasteride groups. The x-axis represents time points from Baseline to Year 4, and the y-axis shows mean change from baseline in unspecified units. Two lines illustrate the data trends, one labeled Placebo and the other Finasteride, with sample sizes noted below at each time point.*
FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
A line graph comparing the percentage of patients showing a specific effect over observation time in months for Finasteride versus placebo. The x-axis represents observation time from 0 to 48 months, and the y-axis represents the percentage of patients from 0% to 15%. Two lines are plotted, one for Finasteride and one for placebo, showing differences in patient response rates over time.*
FDA Label Image

Image Of Figure 3 (Figure 3)

Image Of Figure 3 (Figure 3)
A line graph showing mean percent change from baseline on the vertical axis over a period of four years (baseline through year 3). Two lines represent data for Placebo and Finasteride groups, with the number of participants noted below. The Placebo group shows an increase, while the Finasteride group shows a decrease in the measured variable over time.*
FDA Label Image

Image (Image)

Image (Image)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.